May
TROPHY is an annual contest with the main objective of encouraging residents and fellows in ophthalmology to play a predominant role in their discipline by submitting their clinical cases in order to share their experience.
TROPHY, the “Théa euRopean cOntest of clinical cases in PatHologies of the eYe”, is an annual contest which aims to encourage fellows and residents to actively participate in their speciality by sharing the results of their clinical cases and their experience. Each year there is a specific theme. Three winners are designated by experts who deliberate confidentially and objectively and are invited by Théa to present their clinical case at the Théa symposium which is organised alongside the ARVO congress. The “Théa International Contest of Clinical Cases in Pathologies of the Eyes” promotes exchange between fellows and residents worldwide and offers them a motivating challenge.
Since it was first launched in 2012, more than 1,800 YOs have taken part in TROPHY with a broader international interest every year, and the participation of new countries.
The 2025-2026 TROPHY contest will focus on “Mastering the art of slowing glaucoma progression”. The competition will open in early May and close on October 12th. Stay tuned for more details on how to participate!
More informations: www.thea-trophy.com
You must be logged in to your Théacademy account to have access to this page.
Don't have an account ? Register
Le informamos que, haciendo click en este enlace, accederá a una plataforma externa ajena a Theacademy, responsabilidad de 4DOCTORS S.L., para realizar la formación online « ARVO 2025 – The 12th edition of the Trophy Award Ceremony! ». Para ello, es necesario que se cedan los datos personales imprescindibles para la impartición y entrega de la consiguiente certificación, una fois finalizada.
Mediante la aceptación de esta casilla, confirma que ha sido informado/a y da su consentimiento para ceder sus datos personales y acceder a la formación.
There is no site Thea Academy for your country yet.
You can visit our global site or choose another one:
~ OR ~